Assembly Biosciences, Inc.

ASMB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007
Operating Activities
Net Income $-4.5M $-8.8M $-4.6M
Depreciation & Amortization
Depreciation $7.5K
Amortization
Stock-Based Compensation $123.8K
Net Cash from Operating Activities $-3.5M
Investing Activities
Capital Expenditures $2.6K
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $3.6M
Net Change in Cash $65.4K
Free Cash Flow $-3.5M
← Newer Page 3 of 3 Older →